Adelene Q. Perkins - Jan 11, 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Chief Executive Officer, Director
Signature
/s/Adelene Perkins
Stock symbol
INFI
Transactions as of
Jan 11, 2022
Transactions value $
$0
Form type
4
Date filed
1/12/2022, 04:00 PM
Previous filing
Jan 6, 2022
Next filing
Jan 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +576K $0.00 576K Jan 11, 2022 Common Stock 576K $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.